Home » Pfizer Drug Shows Mixed Results in Psoriasis Trials
Pfizer Drug Shows Mixed Results in Psoriasis Trials
A high dose of Pfizer’s tofacitinib has proven as effective as Enbrel in treating psoriasis, while a lower dose proved less effective. The results suggest that the drug would not be in high demand after the study.
Reuters
Reuters
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May